Migraine & Headache
Approximately 40% of patients with episodic migraine who were treated with galcanezumab achieved 100% response rate for at least 1 month.
Investigators examined the link between migraine and attention-deficit/hyperactivity disorder.
Investigators examined opioid prescribing trends in children and adolescents with primary headaches during ambulatory and emergency department visits.
The safety and efficacy of oxygen treatment for cluster headache attacks with oxygen delivered at a flow rate of 7 L/min and 12 L/min may be comparable.
Abnormal sleep latency and impaired function related to concentration issues may occur more frequently in patients with chronic vs episodic migraine.
Researchers and pain experts formulated guidelines for the use of onabotulinumtoxinA for the management of chronic migraine.
Injections of onabotulinumtoxinA at the sphenopalatine ganglion provide long-term relief for patients with chronic cluster headaches.
The European Headache Federation has issued recommendations on how to best diagnose and treat idiopathic intracranial hypertension.
The continued observation of this delayed headache syndrome may point to a different pathophysiology from tension-type headache or acute poststroke headache.
The effectiveness, tolerability, and use of inhaled oxygen compared with injectable sumatriptan was examined by utilizing a patient reported survey.
Investigators examine risk factors associated with suicide attempt in patients with status migrainosus
Investigators used a survey to better understand whether headache specialists adhere to headache management protocols and the strategies used to prevent ED visits for headache.
Recent high-quality clinical trial evidence has demonstrated that medications commonly prescribed for migraine prevention in pediatric patients were not superior to placebo for reducing headache symptoms.
Recommendations on the use of these agents in this patient population were published in a Views and Perspectives paper in the journal Headache.
A significantly lower percentage of patients receiving a 70-mg or 140-mg dose of erenumab had severe disability during treatment compared with placebo.
Individuals who experience insomnia may be more likely to have migraine and non-migraine headache compared with those without insomnia.
Mindfulness-based practices and treatment programs may be associated with similar changes in plasma levels of catecholamines compared with pharmacologic prophylaxis in patients with migraine and medication overuse headache.
Patients with tension-type or migraine headaches often exhibit myofascial trigger points, but the involvement of these trigger points in the pathophysiology of these conditions is not well understood.
Further research is needed to assess the relationship between estrogen and progestogens on migraines in women.
Investigators examined imaging data of 4 patients with familial hemiplegic migraine attacks subtype 2 to determine distinct imaging finds.
Investigators sought to determine characteristics associated with intracranial vertebral artery dissection-related headache.
Investigators examined the role of thyroid function in patients with migraine and whether there is an association with severity of symptoms with thyroid hormone levels.
Investigators assess whether pretreatment with sumatriptan prevents headaches induced by cilostazole in healthy volunteers.
Poor sleep quality is prevalent among patients with probable migraine and is associated with an exacerbation of probable migraine symptoms.
The primary efficacy endpoint was the mean change from baseline in the monthly average number of headache days of at least moderate severity during the 3-month treatment period.
Galcanezumab treatment may result in functional improvements and a reduction in the impact of headaches on quality of life in patients with migraine.
The preictal phase may be characterized by a reduction in habituation in patients with migraine.
Local ischemia after an acute ischemic stroke may trigger a widely migrating cortical wave of spreading depolarization, which may present as migraine aura.
Adolescents who have asthma or allergic rhinitis may be at higher risk for developing migraine.
Men were not only less likely to consult a doctor for their migraines than women, they were also less likely to be diagnosed with migraine.
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- Predicting the Magnitude of Placebo Analgesia in Chronic Pain
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Examining the Efficacy of Different Oxygen Flow Rates for Cluster Headache Attacks
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- Half of the Responders to Our Poll Agree With the Approval of Dsuvia: We Want to Hear From You
- Daily Alcohol Use May Drive Chronic Pain in Adults With HIV
- Tools to Address the Opioid Crisis
- AHA/ACC Release Updated Guidelines for Cholesterol Management
- Women Fed Soy Formula as Infants More Likely to Experience Menstrual Pain